Download PDF
CC BY-NC-ND 4.0 · Journal of Fetal Medicine 2023; 10(04): 158-163
DOI: 10.1055/s-0044-1778738
SFM Practice Guidelines

SFM Fetal Therapy Practice Guidelines: Fetal Shunts

K. Manikandan
1   Department of Fetal Therapy, The Fetal Clinic, Pondicherry, India
,
Reema Bhatt 
2   Department of Fetal Medicine and Perinatology, Amrita Hospital and Research Institute, Faridabad, Haryana, India
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Fetal shunt is placed into the fetus in order to drain fluid from a fluid-filled fetal area into the amniotic cavity. The main indications are hydrothorax, congenital pulmonary airway malformation (CPAM) with dominant cyst, and lower urinary tract obstruction.

Fetal shunt is indicated if the hydrothorax is primary or hypertensive. In case of re-accumulation after a diagnostic tap or if the primary hydrothorax has led to a secondary nonimmune hydrops provided the primary nature is clearly established and in cases where gestational age is less than 34 weeks.

A shunt in CPAM is indicated in case of CPAM with a dominant cyst where the CPAM volume ratio (CVR) is greater than 1.6, where macrocysts are visible within the lesion, where the diameter of the dominant cyst is more than one-third of the largest diameter of the lesion and where presence of hydrops is not a contraindication for shunting. In case of lower urinary tract obstruction, fetal shunt may be indicated if the following conditions are met. The etiology of lower urinary tract obstruction is posterior urethral valve with oligohydramnios and fetal urinalysis is favorable.

Keywords

CPAM with dominant cyst - hydrothorax - KCH-rocket fetal bladder stent - lower urinary tract obstruction - Harrison fetal bladder stent


Publication History

Article published online:
20 March 2024

© 2024. Society of Fetal Medicine. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • Suggested Reading

  • 1 Morris RK, Malin GL, Quinlan-Jones E. et al; Percutaneous vesicoamniotic shunting in Lower Urinary Tract Obstruction (PLUTO) Collaborative Group. Percutaneous vesicoamniotic shunting versus conservative management for fetal lower urinary tract obstruction (PLUTO): a randomised trial. Lancet 2013; 382 (9903): 1496-1506
    Google Scholar
  • 2 Nicolaides KH, Azar GB. Thoraco-amniotic shunting. Fetal Diagn Ther 1990; 5 (3–4): 153-164
    CrossrefPubMedGoogle Scholar
  • 3 Peranteau WH, Adzick NS, Boelig MM. et al. Thoracoamniotic shunts for the management of fetal lung lesions and pleural effusions: a single-institution review and predictors of survival in 75 cases. J Pediatr Surg 2015; 50 (02) 301-305
    CrossrefPubMedGoogle Scholar